The decision clears ... an updated COVID-19 vaccine to provide better protection against currently circulating variants," said Dr. Peter Marks, Director of the FDA's Center for Biologics ...

It’s time to start thinking about fall virus protection, the CDC and FDA ... vaccine, with a 2-month interval since the last dose of any COVID vaccine. The recommendations for the RSV vaccine ...

New Covid-19 shots are on their way, leaving plenty of time to get them before respiratory illness season this fall.

The U.S. Food and Drug Administration (FDA) has approved updated COVID-19 vaccines from Moderna and Pfizer for the 2024-2025 season. The updated mRNA vaccines, Comirnaty and Spikevax, were fully ...

but the FDA should engage more effectively as well. The decision prolongs — probably for a decade — the availability of much-needed treatments. It is harmful, for all the veterans and millions ...

A third U.S. manufacturer, Novavax, expects its modified vaccine version to ... circulating variants,” said FDA vaccine chief Dr. Peter Marks. The agency’s decision came a bit earlier than ...

Analyst Ryan Deschner said that the FDA's decision eliminates uncertainty over Yutrepia approval and provides confidence the drug will receive final approval in both indications. The firm had ...

There are certain types of clinical studies that would not support exclusivity, and Liquidia argues this includes the study that the FDA has based its decision on. "FDA exceeded its statutory ...

The biopharmaceutical company said the FDA decision on the drug was pushed back three months from the original Sept. 26 date. Syndax shares moved sharply lower on Monday. Shares of Syndax ...

Respiratory syncytial virus (RSV ... of an RSV vaccine. The F protein exists as a trimer in both prefusion and postfusion forms that can elicit neutralizing antibodies. The US FDA-approved ...

Previously, a mother whose two children were admitted to hospital after contracting a respiratory virus urged pregnant women to accept the new NHS vaccine. RSV can lead to severe lung infections ...

The Drug Enforcement Administration has scheduled a hearing on the Biden administration’s proposal to reclassify marijuana under federal drug laws, effectively delaying the decision until after ...